GO:0061666 UFM1 ligase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061666 (UFM1 ligase activity) describes the enzymatic transfer of UFM1 from an E2 or E3 thioester intermediate to the epsilon-amino group of lysine residues in a substrate protein, forming an isopeptide bond.
• The principal UFM1 E3 ligase is UFL1, which together with UFC1 (E2), UBA5 (E1), UFBP1/DDRGK1 and UFM1 itself forms the core UFM1 conjugation machinery.
• UFM1 ligase activity is best known for UFMylating ribosomal protein RPL26 and for regulating ER stress, ribosome quality control and the ribosomal DNA-damage response.
• Substrates of UFM1 ligase activity include BECN1, MAVS, NLRP3, alpha-synuclein and nascent GPCRs, linking the enzyme to autophagy, innate immunity, inflammasome activation, neurodegeneration and ER-Golgi transport.
• Dysregulated UFM1 ligation is implicated in cancer, neurodegeneration, inflammatory disease and ER-stress-related pathology, making it an emerging therapeutic target.
• CRISPR knockout, point-mutation, knock-in and overexpression models are the primary tools for dissecting UFM1 ligase substrate specificity and disease relevance.
Description
UFM1 ligase activity (GO:0061666) is a molecular function that catalyzes the final step of protein UFMylation, a ubiquitin-like modification in which the small protein UFM1 is covalently attached to substrate lysines. The reaction proceeds through a thioester-linked UFM1 intermediate on an E2 or E3 enzyme and ends with an isopeptide bond between the C-terminal glycine of UFM1 and the epsilon-amino group of a substrate lysine. This activity is essential for the UFM1 conjugation system, a conserved stress-responsive pathway that operates at the endoplasmic reticulum and the ribosome. Researchers study UFM1 ligase activity because it controls diverse cellular processes, including ER stress responses, ribosome quality control, autophagy initiation, innate immune signaling and ER-to-Golgi transport of nascent proteins. The best-characterized E3 ligase for this reaction is UFL1, which cooperates with the E1 enzyme UBA5, the E2 enzyme UFC1 and the adaptor UFBP1/DDRGK1 to transfer UFM1 to substrates such as RPL26, BECN1, MAVS, NLRP3 and alpha-synuclein. Because loss or dysregulation of UFM1 ligation is linked to neurodegeneration, inflammatory disease and cancer, the enzyme is a growing focus for functional genomics and drug discovery. This article summarizes the QuickGO definition of GO:0061666, the core enzymatic mechanism, the key genes and substrates, disease connections and the CRISPR-based experimental models used to study UFM1 ligase activity.
UFM1 ligase activity At A Glance
| GO ID | GO:0061666 |
|---|---|
| GO term | UFM1 ligase activity |
| Ontology | molecular_function |
| Synonym | E3 |
| Definition | Catalysis of the transfer of UFM1 to a substrate protein via X-UFM1 + S = X + S-UFM1, where X is an E2 or E3 enzyme, the X-UFM1 linkage is a thioester bond, and the S-UFM1 linkage is an isopeptide bond between the C-terminal amino acid of UFM1 and the epsilon-amino group of lysine residues in the substrate. |
| Major function | Final E3-dependent conjugation of UFM1 to substrate lysines |
| Core enzyme | UFL1 (UFM1-specific E3 ligase) |
| Cofactors / adaptors | UBA5 (E1), UFC1 (E2), UFBP1/DDRGK1, UFM1 |
| Representative substrates | RPL26, BECN1, MAVS, NLRP3, alpha-synuclein, nascent GPCRs |
| Associated biology | ER stress, ribosome quality control, autophagy, innate immunity, ER-Golgi transport |
What Is GO:0061666?
UFM1 ligase activity (GO:0061666) is the catalytic activity that transfers UFM1 from a thioester-linked E2 or E3 intermediate to a substrate protein, forming an isopeptide bond between the C-terminal amino acid of UFM1 and the epsilon-amino group of a lysine residue in the substrate. In the reaction X-UFM1 + S = X + S-UFM1, X represents the E2 or E3 enzyme, the X-UFM1 linkage is a thioester, and the S-UFM1 linkage is an isopeptide bond. This activity represents the E3 step of the UFM1 conjugation cascade and is distinct from E1 activating and E2 conjugating activities.
Why Is UFM1 ligase activity Important in Cell Biology?
UFM1 ligase activity is important because it defines the committed step of UFMylation, a ubiquitin-like modification that cells use to monitor ER and ribosomal stress and to tune autophagy, innate immune signaling and protein trafficking. Perturbing this activity changes the stability and localization of key substrates such as BECN1, MAVS, NLRP3 and alpha-synuclein, which directly affects autophagy initiation, antiviral responses, inflammasome activation and proteostasis. As a result, GO:0061666 is a central node for understanding stress surveillance in human disease and for designing targeted CRISPR models.
• Defines the E3 step of the UFM1 conjugation cascade, the committed reaction that determines substrate specificity.
• Controls ER stress responses through UFL1 and the UFM1 system.
• Regulates ribosome quality control and the ribosomal DNA-damage response via RPL26 UFMylation.
• Modulates autophagy initiation by stabilizing BECN1 through VCP/p97-dependent UFMylation.
• Shapes innate immune signaling by UFMylating MAVS and NLRP3.
• Influences neurodegeneration through mono-UFMylation of alpha-synuclein and misfolding-associated secretion.
• Regulates COPII recruitment and anterograde transport of nascent GPCRs at the ER.
• Is implicated in cancer, inflammatory disease and ER-stress-related pathology.
• Provides a tractable target for CRISPR knockout, point-mutation and knock-in studies.
• Offers opportunities for small-molecule or genetic modulation of stress surveillance pathways.
What Happens During UFM1 ligase activity?
Activation of UFM1 by the E1 enzyme UBA5
In simple terms: UFM1 must first be switched on by an activating enzyme before it can be attached to a target protein.
In the UFM1 conjugation cascade, the E1 enzyme UBA5 activates UFM1 in an ATP-dependent manner and forms a thioester with the UFM1 C-terminus. This step precedes the E3 ligase reaction and provides the charged UFM1 that will be transferred to the E2 enzyme UFC1. The UFM1 system is a conserved ubiquitin-like pathway that responds to cellular stress, and its E1 step is required for all downstream UFM1 ligase activity.
Transesterification to the E2 enzyme UFC1
In simple terms: The activated UFM1 is handed to a carrier enzyme that will deliver it to the E3 ligase.
UFC1 is the E2 conjugating enzyme for UFM1 and receives UFM1 from UBA5 through a transthioesterification reaction, forming a UFC1-UFM1 thioester. This E2-UFM1 intermediate is the X-UFM1 species described in the GO:0061666 definition, where X can be either an E2 or E3 enzyme. The E2 enzyme then interacts with the E3 ligase UFL1 to position UFM1 for substrate modification.
E3 ligase UFL1 and adaptor UFBP1/DDRGK1
In simple terms: The E3 ligase is the matchmaker that brings UFM1 close to the correct target protein.
UFL1 is the principal UFM1 E3 ligase and, together with the adaptor UFBP1/DDRGK1, forms the core E3 complex that catalyzes isopeptide bond formation between UFM1 and substrate lysines. UFL1/RCAD has an intricate connection with ER stress, and its activity is required for UFMylation of ribosomal and ER-associated substrates. The E3 complex determines substrate selection and is therefore the key specificity determinant of GO:0061666.
Isopeptide bond formation on substrate lysines
In simple terms: UFM1 is stapled onto a lysine on the target protein, changing what that protein does.
In the final catalytic step, UFM1 is transferred from the E2 or E3 thioester to the epsilon-amino group of a lysine residue in the substrate, forming a stable isopeptide bond. This reaction defines GO:0061666 and produces mono- or multi-UFMylated substrates depending on the target. Substrates include RPL26 in the ribosome, BECN1 in autophagy, MAVS and NLRP3 in innate immunity, alpha-synuclein in neurodegeneration and nascent GPCRs in ER export.
Downstream consequences for substrate fate
In simple terms: Once UFM1 is attached, the target protein may be stabilized, relocated or targeted for degradation.
UFMylation can alter substrate stability, localization and interactions. For example, VCP/p97-dependent UFMylation stabilizes BECN1 and facilitates autophagy initiation, while UFMylation of NLRP3 prevents its autophagic degradation and facilitates inflammasome activation. Mono-UFMylation of alpha-synuclein promotes misfolding-associated secretion, and UFMylation of nascent GPCRs controls COPII recruitment and anterograde transport at the ER. These outcomes illustrate how GO:0061666 translates into diverse cell biological effects.
Key Genes Involved in GO:0061666 UFM1 ligase activity
The following genes and proteins constitute or regulate the UFM1 ligase activity (GO:0061666) system and its best-characterized substrates.
| Gene | Major Role | Research Relevance |
|---|---|---|
| UFM1 | Ubiquitin-like modifier transferred to substrates | Core substrate of GO:0061666; essential for all UFMylation assays |
| UBA5 | E1 activating enzyme for UFM1 | Required for UFM1 charging and downstream ligase activity |
| UFC1 | E2 conjugating enzyme for UFM1 | Forms the E2-UFM1 thioester intermediate |
| UFL1 | Principal UFM1 E3 ligase | Catalytic core of GO:0061666; linked to ER stress |
| UFBP1/DDRGK1 | Adaptor in the UFL1 E3 complex | Required for efficient substrate UFMylation |
| RPL26 | Ribosomal protein substrate | UFMylation regulates ribosome quality control and rDNA damage response |
| BECN1 | Autophagy initiator substrate | VCP/p97-dependent UFMylation stabilizes BECN1 and promotes autophagy |
| MAVS | Mitochondrial antiviral signaling substrate | UFMylation modulates innate immune signaling and inflammasome evasion |
| NLRP3 | Inflammasome sensor substrate | UFMylation prevents autophagic degradation and facilitates inflammasome activation |
| SNCA (alpha-synuclein) | Neurodegeneration-related substrate | Mono-UFMylation promotes misfolding-associated secretion |
| VCP/p97 | AAA+ ATPase cofactor | Facilitates UFMylation-dependent stabilization of BECN1 |
| COPII components | ER export machinery | UFMylation controls COPII recruitment and GPCR transport |
| UBA5-UFC1-UFL1 axis | Core conjugation cascade | Central to all GO:0061666 functional studies |
| UFSP2 | UFM1-specific protease (deconjugating) | Balances UFMylation by removing UFM1 from substrates |
| ER stress sensors (ERN1/ATF6) | Stress signaling | UFM1 ligase activity is connected to ER stress responses |
| Ribosomal DNA damage factors | rDNA damage response | UFMylation regulates early events in rDNA damage signaling |
| GPCRs | Nascent ER cargo | UFMylation affects COPII recruitment and anterograde transport |
How Is UFM1 ligase activity Regulated?
UFM1 ligase activity is regulated at multiple levels. The E3 ligase UFL1 and its adaptor UFBP1/DDRGK1 form the core catalytic complex, and their expression or assembly controls substrate selection. The pathway is responsive to ER stress, which is intimately connected to UFL1/RCAD function. UFMylation is reversible: the UFM1-specific protease UFSP2 removes UFM1 from substrates, providing a dynamic balance with ligase activity. In addition, cofactors such as VCP/p97 modulate UFMylation-dependent substrate fate, as shown for BECN1 stabilization during autophagy initiation. The UFM1 conjugation system is increasingly viewed as a master regulator of cellular stress surveillance, integrating ER, ribosomal and immune signals.
UFM1 ligase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SNCA | Parkinson's disease / synucleinopathy | Neuronal knock-in of UFM1-site mutations in SNCA |
| NLRP3 | Inflammatory disease / inflammasome activation | Macrophage knockout of UFL1 or NLRP3 UFMylation-site knock-in |
| MAVS | Antiviral innate immunity / inflammasome evasion | MAVS UFMylation-site point-mutant cells |
| BECN1 | Autophagy-related cancer and stress survival | BECN1 UFMylation-site knock-in and UFL1 knockout |
| UFL1 | ER stress and cancer | UFL1 knockout and overexpression cell models |
UFM1 ligase activity in neurodegeneration
Mono-UFMylation of alpha-synuclein promotes misfolding-associated secretion, a process relevant to synucleinopathies such as Parkinson's disease. Because UFM1 ligase activity controls the fate of aggregation-prone proteins, its dysregulation may contribute to proteostatic stress in neurons. The UFM1 conjugation system is broadly implicated in neurodegenerative disease through its role in stress surveillance.
UFM1 ligase activity in inflammatory and innate immune disease
UFMylation of MAVS modulates innate immune signaling and is targeted by viral proteins such as an Epstein-Barr virus protein that evades NLRP3 inflammasome activation. UFMylation of NLRP3 prevents its autophagic degradation and facilitates inflammasome activation, linking GO:0061666 to inflammatory disease. These findings position UFM1 ligase activity as a regulator of antiviral and inflammatory responses.
UFM1 ligase activity in cancer and ER stress
The UFM1 conjugation system is a master regulator of cellular stress surveillance in human disease, including cancer. UFL1/RCAD, the UFM1 E3 ligase, has an intricate connection with ER stress, a pathway frequently rewired in tumors. UFMylation of BECN1 supports autophagy initiation, a process that can influence tumor cell survival under stress.
UFM1 ligase activity in ribosomopathy and genome stability
Protein UFMylation regulates early events during the ribosomal DNA-damage response, connecting GO:0061666 to genome stability and ribosome biology. UFMylation of ribosomal protein RPL26 is a key example of how ligase activity maintains ribosome quality control. Defects in this axis may contribute to ribosome-related stress syndromes.
From UFM1 ligase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is UFL1 required for substrate UFMylation? | UFL1 knockout cell line |
| Which lysine on the substrate accepts UFM1? | Point-mutation knock-in of substrate lysine to arginine |
| Does UFMylation stabilize or degrade the substrate? | Tagged knock-in of the substrate with a degron or fluorescent tag |
| Can UFM1 ligase activity be enhanced or inhibited? | Overexpression of UFL1, UFBP1 or UFM1 |
| Does UFMylation control ER export of cargo? | Knockout or point-mutant cells combined with imaging of nascent GPCRs |
| Does UFMylation regulate rDNA damage signaling? | Knockout of UFM1 pathway genes plus rDNA damage assays |
How to Study the UFM1 ligase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS proteomics | UFMylated peptides and substrate lysines | Global UFMylome mapping |
| In vitro UFMylation assay | Isopeptide bond formation on substrate | Testing E3 requirements for GO:0061666 |
| Western blot with anti-UFM1 | Steady-state UFM1 conjugates | Validating knockout or overexpression effects |
| Fluorescence imaging | Substrate localization and trafficking | GPCR ER export and COPII recruitment |
| Autophagy flux assay | Autophagosome initiation and BECN1 stability | Autophagy regulation by UFMylation |
| Inflammasome activation assay | NLRP3 speck formation and IL-1beta release | Inflammatory signaling studies |
| rDNA damage assay | Ribosomal DNA damage response | Genome stability studies |
| RNA-seq | Transcriptional stress and immune programs | Pathway-level readout of UFM1 ligase loss |
Proteomic detection of UFMylated substrates
Mass spectrometry-based proteomics can identify UFM1-modified proteins and map the modified lysine residues, providing a global view of GO:0061666 substrates. Enrichment of UFM1 conjugates followed by LC-MS/MS is a standard approach to define the UFMylome. Such datasets help prioritize substrates for functional validation.
Biochemical assays for UFM1 ligase activity
In vitro reconstitution with recombinant UBA5, UFC1, UFL1, UFBP1 and UFM1 allows direct measurement of isopeptide bond formation on substrate proteins. These assays can test whether a candidate E3 or adaptor is required for UFM1 transfer. They also enable kinetic and specificity studies of GO:0061666.
Cell-based imaging and trafficking assays
Fluorescence imaging of tagged substrates and ER markers can reveal how UFMylation alters localization, as shown for nascent GPCRs and COPII recruitment. Live-cell imaging of autophagy markers can assess BECN1 stabilization and autophagosome initiation. Imaging of inflammasome speck formation can test NLRP3 UFMylation effects.
Transcriptomic and stress-response profiling
RNA-seq and stress-response reporter assays can measure how loss of UFM1 ligase activity reshapes ER stress, immune and autophagy gene programs. Combining transcriptomics with proteomics links GO:0061666 to downstream cellular states. These approaches are useful for identifying disease-relevant pathways.
How CRISPR Can Be Used to Study GO:0061666 UFM1 ligase activity
Knockout
CRISPR knockout of UFL1, UBA5, UFC1 or UFBP1/DDRGK1 abolishes UFM1 ligase activity and reveals which substrates and pathways depend on GO:0061666. Knockout of UFL1 is a standard approach to test ER stress, autophagy and immune phenotypes. Knockout models also help distinguish UFMylation from other ubiquitin-like modifications.
Point Mutation
Point mutation of the acceptor lysine in a substrate to arginine prevents UFM1 attachment and tests the functional importance of a single UFMylation site. Such models are valuable for substrates like NLRP3, MAVS and alpha-synuclein where site-specific UFMylation drives a phenotype. Point mutation of catalytic residues in UFL1 can also separate ligase activity from scaffolding functions.
Knock-in
Knock-in of epitope or fluorescent tags on UFM1, UFL1 or substrates enables tracking of UFM1 ligase activity in live cells. Knock-in of disease-relevant substrate mutations can model how altered UFMylation contributes to neurodegeneration or inflammation. Tagged knock-in lines are also useful for proteomic enrichment of UFMylated proteins.
Overexpression
Overexpression of UFL1, UFBP1/DDRGK1 or UFM1 boosts UFM1 ligase activity and can reveal gain-of-function phenotypes in stress and immune pathways. Overexpression models complement knockout studies by testing sufficiency of the UFM1 cascade. They are also used to amplify signal in biochemical and imaging assays.
How EDITGENE Supports UFM1 ligase activity Research
Researchers studying UFM1 ligase activity-related genes often need to determine whether a candidate gene is causally involved in substrate UFMylation, stress responses or disease phenotypes. EDITGENE provides publication-grade CRISPR cell models and screening services that let you move from candidate gene to mechanistic evidence efficiently.
Contact EDITGENE today to design your custom CRISPR model for UFM1 ligase activity research.
Frequently Asked Questions About UFM1 ligase activity
What is UFM1 ligase activity?
UFM1 ligase activity (GO:0061666) is the enzymatic transfer of UFM1 from an E2 or E3 thioester intermediate to a substrate lysine, forming an isopeptide bond.
What genes are involved in UFM1 ligase activity?
Core genes include UFM1, UBA5, UFC1, UFL1 and UFBP1/DDRGK1, with substrates such as RPL26, BECN1, MAVS, NLRP3 and alpha-synuclein.
Which enzyme is the main UFM1 E3 ligase?
UFL1 is the principal UFM1 E3 ligase and works with the adaptor UFBP1/DDRGK1.
What is the difference between UFM1 ligase activity and ubiquitin ligase activity?
UFM1 ligase activity transfers the ubiquitin-like protein UFM1 rather than ubiquitin, and it forms an isopeptide bond on substrate lysines as defined for GO:0061666.
How is UFM1 ligase activity regulated?
It is regulated by the assembly of the UFL1-UFBP1 E3 complex, by ER stress, and by the opposing deconjugating protease UFSP2.
What diseases are linked to UFM1 ligase activity?
It has been linked to neurodegeneration, inflammatory and innate immune disease, cancer and ribosome-related genome instability.
How do researchers measure UFM1 ligase activity?
Common methods include in vitro UFMylation assays, anti-UFM1 western blots, LC-MS/MS proteomics and imaging of tagged substrates.
Can CRISPR knockout be used to study UFM1 ligase activity?
Yes, knockout of UFL1, UBA5, UFC1 or UFBP1/DDRGK1 is widely used to abolish UFM1 ligation and test downstream phenotypes.
What are the best cell models for UFM1 ligase research?
Knockout, point-mutation, knock-in and overexpression cell lines in relevant backgrounds are standard, depending on the substrate and pathway studied.
Why is UFM1 ligase activity important for autophagy?
UFMylation stabilizes BECN1 in a VCP/p97-dependent manner and facilitates autophagy initiation.
Conclusion
UFM1 ligase activity (GO:0061666) is the E3-dependent step that covalently attaches UFM1 to substrate lysines, and it sits at the center of a conserved stress-surveillance system. Its substrates connect the enzyme to autophagy, innate immunity, inflammasome biology, ER-Golgi transport, neurodegeneration and genome stability. Understanding this activity requires combining biochemical assays, proteomics and CRISPR models that manipulate UFL1, UBA5, UFC1, UFBP1/DDRGK1 and substrate UFMylation sites. As the UFM1 conjugation system emerges as a master regulator of cellular stress in human disease, precise CRISPR cell models will be essential for translating substrate-level findings into therapeutic hypotheses.
References
- 1. Wang Z et al.. 2024. VCP/p97 UFMylation stabilizes BECN1 and facilitates the initiation of autophagy.. Autophagy 20(9):2041-2054 PMID: 38762759
- 2. Wang L et al.. 2024. Mono-UFMylation promotes misfolding-associated secretion of α-synuclein.. Sci Adv 10(11):eadk2542 PMID: 38489364
- 3. Yiu SPT et al.. 2023. An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation.. Mol Cell 83(13):2367-2386.e15 PMID: 37311461
- 4. Xie Z et al.. 2019. Ufl1/RCAD, a Ufm1 E3 ligase, has an intricate connection with ER stress.. Int J Biol Macromol 135:760-767 PMID: 31129212
- 5. Jing J et al.. 2025. UFMylation of NLRP3 Prevents Its Autophagic Degradation and Facilitates Inflammasome Activation.. Adv Sci (Weinh) 12(15):e2406786 PMID: 39985286
- 6. Kuang M et al.. 2026. The UFM1 Conjugation System: A Master Regulator of Cellular Stress Surveillance in Human Disease.. Biology (Basel) 15(5) PMID: 41823810
- 7. Xu X et al.. 2024. The ufmylation cascade controls COPII recruitment, anterograde transport, and sorting of nascent GPCRs at ER.. Sci Adv 10(25):eadm9216 PMID: 38905340
- 8. Panichnantakul P et al.. 2024. Protein UFMylation regulates early events during ribosomal DNA-damage response.. Cell Rep 43(9):114738 PMID: 39277864
